Heteroryl-fused pyrimidinyl compounds as anticancer agents

Details for Australian Patent Application No. 2004247650 (hide)

Owner Chiron Corporation

Inventors Constantine, Ryan N.; Wang, Weibo; Lagniton, Liana M.; Burger, Matthew T.

Agent FB Rice

Pub. Number AU-A-2004247650

PCT Pub. Number WO2004/111058

Priority 60/474,684 30.05.03 US

Filing date 27 May 2004

Wipo publication date 23 December 2004

International Classifications

C07D 495/04 Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms

A61K 031/519 - ortho- or peri-condensed with heterocyclic rings

A61P 035/00 Antineoplastic agents

Event Publications

1 December 2005 PCT application entered the National Phase

  PCT publication WO2004/111058 Priority application(s): WO2004/111058

20 November 2008 Alteration of Name

  The name of the applicant has been altered to Novartis Vaccines and Diagnostics, Inc.

23 December 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004247652-Wear resistant component

2004247640-Gas phase polymerization and method of controlling same